SERUM INFLAMMATORY PROTEIN PROFILING TO CORROBORATE SELECTION OF THERAPY NAÏVE MODERATE-TO-SEVERE PAEDIATRIC CROHN’S DISEASE PATIENTS ELIGIBLE FOR FIRST-LINE INFLIXIMAB

Maria Myrthe Elisabeth Jongsma  ¹     Léa M. M. Costes  ¹     Irma Tindemans  ¹     Martinus A. Cozijnsen  ¹     H.C. Raatgeep  ¹     Merel van Pieterson  ¹     Yunlei Li  ²     Johanna C. Escher  ²     Lissy de Ridder  ²     Janneke N Samsom  ^2    
1 Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands
² Erasmus MC, Rotterdam, Netherlands

Topic
Disease Mechanisms, IBD, Immunology, Paediatrics

Session
IBD prediction and prognosis

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)